|

Talazoparib Tosylate Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Talzenna

Pipeline

Phase 1: 2

Top Sponsors

  • Roswell Park Cancer Institute1
  • M.D. Anderson Cancer Center1

Indications

  • Advanced Malignant Solid Neoplasm2
  • Cancer2
  • Stage IIIC Colorectal Cancer AJCC v81
  • Stage IIIB Colorectal Cancer AJCC v81
  • Stage IIIA Colorectal Cancer AJCC v81

Buffalo, New York1 trial

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Roswell Park Cancer Institute

Phase 1

Houston, Texas1 trial

Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

M D Anderson Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.